Large-Cap Stocks Underperform: Synopsys, Chewy, Trade Desk Among Top 10 Losers
PorAinvest
lunes, 15 de septiembre de 2025, 2:17 am ET1 min de lectura
CHWY--
Synopsys, a leading provider of chip design software, saw its stock plunge 29.20% following the release of its third-quarter results. The company reported revenue of $1.74 billion, falling short of analyst estimates of $1.77 billion. Adjusted earnings per share (EPS) also missed expectations, coming in at $3.39 compared to the anticipated $3.74. The underperformance was primarily attributed to weaknesses in the Design IP business, including disrupted design starts in China, challenges at a major foundry customer, and internal roadmap issues [1].
Chewy, a popular online pet supply retailer, saw its stock drop 18.05% after reporting second-quarter results. Despite revenue and EPS meeting expectations, the company's 79% fall in net profit and less-than-expected investment into the business raised concerns. JP Morgan maintained its 'Overweight' rating on Chewy stock but noted that the over 16% drop was an overreaction to the company's financials. The company's full-year sales forecast was also boosted, but the stock's decline was attributed to margin compression worries [2].
The Trade Desk, a digital ad tech company, faced a 13.75% decline after Morgan Stanley downgraded its stock to "equal weight" from "overweight." The downgrade was driven by mounting concerns about the company's connected TV business, which has been facing headwinds. Morgan Stanley cited their past mistakes in predicting the company's growth [3].
Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores. These companies also reported financial results that fell short of expectations or faced negative analyst commentary.
Investors should closely monitor these large-cap stocks for any signs of recovery or further declines. The recent sell-off highlights the importance of staying informed about company-specific events and market trends.
SNPS--
TTD--
Large-cap stocks Synopsys, Chewy, and The Trade Desk lost 29.20%, 18.05%, and 13.75% respectively last week. The losses were attributed to worse-than-expected financial results, lower price forecasts, and a downgrade from Morgan Stanley. Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores.
Large-cap stocks Synopsys (SNPS), Chewy (CHWY), and The Trade Desk (TTD) experienced significant losses last week, with declines of 29.20%, 18.05%, and 13.75% respectively. The sell-off was driven by a combination of worse-than-expected financial results, lower price forecasts, and downgrades from investment firms.Synopsys, a leading provider of chip design software, saw its stock plunge 29.20% following the release of its third-quarter results. The company reported revenue of $1.74 billion, falling short of analyst estimates of $1.77 billion. Adjusted earnings per share (EPS) also missed expectations, coming in at $3.39 compared to the anticipated $3.74. The underperformance was primarily attributed to weaknesses in the Design IP business, including disrupted design starts in China, challenges at a major foundry customer, and internal roadmap issues [1].
Chewy, a popular online pet supply retailer, saw its stock drop 18.05% after reporting second-quarter results. Despite revenue and EPS meeting expectations, the company's 79% fall in net profit and less-than-expected investment into the business raised concerns. JP Morgan maintained its 'Overweight' rating on Chewy stock but noted that the over 16% drop was an overreaction to the company's financials. The company's full-year sales forecast was also boosted, but the stock's decline was attributed to margin compression worries [2].
The Trade Desk, a digital ad tech company, faced a 13.75% decline after Morgan Stanley downgraded its stock to "equal weight" from "overweight." The downgrade was driven by mounting concerns about the company's connected TV business, which has been facing headwinds. Morgan Stanley cited their past mistakes in predicting the company's growth [3].
Other large-cap stocks that lost value include Summit Therapeutics, Rubrik, BioNTech, Ferguson Enterprises, Humana, Samsara, and Burlington Stores. These companies also reported financial results that fell short of expectations or faced negative analyst commentary.
Investors should closely monitor these large-cap stocks for any signs of recovery or further declines. The recent sell-off highlights the importance of staying informed about company-specific events and market trends.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios